Evidence map›Paper›PMID 26803467›Full record

ArticleBMC pulmonary medicine2016

Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells.

Dariimaa Ganbat, Sophie Seehase, Elvira Richter, Ekkehard Vollmer, Norbert Reiling, Kurt Fellenberg, Karoline I Gaede, Christian Kugler, Torsten Goldmann

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Diverse interactions ofFrontiers in tuberculosis · 2024
    Review
  7. Review
  8. Frontiers in cellular and infection microbiology · 2023
    Article
  9. Review
  10. Article
  11. Ocular mycobacterial lesions in cats.Veterinary pathology · 2022
    Article
  12. Review
  13. Uncovering the Mast Cell Response toFrontiers in immunology · 2022
    Review
  14. Virulence Mechanisms ofFrontiers in microbiology · 2022
    Review
  15. Review
  16. Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  17. Review
  18. Neutrophil Dynamics AffectFrontiers in immunology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dariimaa GanbatClinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. amirad_mon@yahoo.com.
Sophie SeehaseClinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. sseehase@fz-borstel.de.
Elvira RichterNational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany. elvira.richter@labor-limbach.de.
Ekkehard VollmerClinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. evollmer@fz-borstel.de.
Norbert ReilingMicrobial Interface Biology, Research Center Borstel, Borstel, Germany. nreiling@fz-borstel.de.
Kurt FellenbergBioinformatics, Research Center Borstel, Borstel, Germany. kfellenberg@fz-borstel.de.
Karoline I GaedeClinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. kgaede@fz-borstel.de.
Christian KuglerAirway Research Center North (ARCN), Member of the German Center for Lung Research, Gießen, Germany. C.Kugler@lungenclinic.de.
Torsten GoldmannClinical and Experimental Pathology, Research Center Borstel, Borstel, Germany. tgoldmann@fz-borstel.de.
Research Center Borstel - Leibniz Lung Center · DEGerman Center for Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMycobacterial infections remain a significant cause of morbidity and mortality worldwide. Due to limitations of the currently available model systems, there are still comparably large gaps in the knowledge about the pathogenesis of these chronic inflammatory diseases in particular with regard to the human host. Therefore, we aimed to characterize the initial phase of mycobacterial infections utilizing a human ex vivo lung tissue culture model designated STST (Short-Term Stimulation of Tissues).

methodsHuman lung tissues from 65 donors with a size of 0.5-1 cm(3) were infected each with two strains of three different mycobacterial species (M. tuberculosis, M. avium, and M. abscessus), respectively. In order to preserve both morphology and nucleic acids, the HOPE® fixation technique was used. The infected tissues were analyzed using histo- and molecular-pathological methods. Immunohistochemistry was applied to identify the infected cell types.

resultsMorphologic comparisons between ex vivo incubated and non-incubated lung specimens revealed no noticeable differences. Viability of ex vivo stimulated tissues demonstrated by TUNEL-assay was acceptable. Serial sections verified sufficient diffusion of the infectious agents deep into the tissues. Infection was confirmed by Ziel Neelsen-staining and PCR to detect mycobacterial DNA. We observed the infection of different cell types, including macrophages, neutrophils, monocytes, and pneumocytes-II, which were critically dependent on the mycobacterial species used. Furthermore, different forms of nuclear alterations (karyopyknosis, karyorrhexis, karyolysis) resulting in cell death were detected in the infected cells, again with characteristic species-dependent differences.

conclusionWe show the application of a human ex vivo tissue culture model for mycobacterial infections. The immediate primary infection of a set of different cell types and the characteristic morphologic changes observed in these infected human tissues significantly adds to the current understanding of the initial phase of human pulmonary tuberculosis. Further studies are ongoing to elucidate the molecular mechanisms involved in the early onset of mycobacterial infections in the human lung.

Indexed as

Alveolar Epithelial CellsCell NucleusHumansImmunohistochemistryIn Situ Nick-End LabelingIn Vitro TechniquesLungLymphocytesMacrophages, AlveolarMonocytesMycobacteriumMycobacterium aviumMycobacterium Infections, NontuberculousMycobacterium tuberculosisNeutrophilsPolymerase Chain Reaction

Identifiers

PMID26803467
PMCPMC4724406
OpenAlexW2253701506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.